| 4-1BB | 4-1BB receptor (CD137; TNFRSF9) |
| 4-1BBL | 4-1BB ligand (TNFSF9) |
| aa | Amino acid(s) |
| ADCC | Antibody-dependent cellular cytotoxicity |
| AML | Acute myeloid leukemia |
| AP-1 | Activator protein 1 |
| APC | Antigen-presenting cell |
| ATL | Adult T-cell leukemia/lymphoma |
| BCR | B-cell receptor |
| BTLA | B- and T-lymphocyte attenuator |
| CAR-T | Chimeric antigen receptor T cell |
| CD | Cluster of differentiation |
| CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 |
| CRD | Cysteine-rich domain |
| CTLA-4 | Cytotoxic T-lymphocyte-associated protein 4 |
| CVID | Common variable immunodeficiency |
| Da | Dalton |
| DC | Dendritic cell |
| DNAM-1 | DNAX accessory molecule-1 (CD226) |
| EMT | Epithelial–mesenchymal transition |
| ERK | Extracellular signal-regulated kinase |
| FcγR | Fc gamma receptor |
| FGL1 | Fibrinogen-like protein 1 |
| GITR | Glucocorticoid-induced TNFR-related protein |
| GITRL | Glucocorticoid-induced TNFR-related protein ligand |
| GVHD | Graft-versus-host disease |
| HAVCR2 | Hepatitis A virus cellular receptor 2 |
| HMGB1 | High mobility group box 1 |
| HVEM | Herpesvirus entry mediator |
| ICOS | Inducible T-cell costimulator |
| ICOSL | Inducible T-cell costimulator ligand |
| IFN-γ | Interferon gamma |
| IgSF | Immunoglobulin superfamily |
| IL | Interleukin (e.g., IL-2, IL-10, IL-12) |
| ICP | Immune checkpoint |
| irAEs | Immune-related adverse events |
| ITIM | Immunoreceptor tyrosine-based inhibitory motif |
| ITSM | Immunoreceptor tyrosine-based switch motif |
| ITT-like | Immunoreceptor tyrosine-based inhibitory motif-like motif |
| LAG-3 | Lymphocyte activation gene 3 |
| LFA-3 | Lymphocyte function-associated antigen 3 (CD58) |
| LIGHT | Homologous to lymphotoxins, exhibits inducible expression, competes with HSV glycoprotein D for HVEM, a receptor expressed by T lymphocytes |
| MAPK | Mitogen-activated protein kinase |
| MDSCs | Myeloid-derived suppressor cells |
| MHC | Major histocompatibility complex |
| mAb | Monoclonal antibody |
| NECTIN2 | Nectin cell adhesion molecule 2 |
| NFAT | Nuclear factor of activated T cells |
| NK | Natural killer cell |
| OX40 | OX40 receptor (TNFRSF4) |
| OX40L | OX40 ligand (TNFSF4) |
| PBMC | Peripheral blood mononuclear cells |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | Programmed death-ligand 1 |
| PD-L2 | Programmed death-ligand 2 |
| PI3K/AKT | Phosphoinositide 3-kinase/Protein kinase B signaling pathway |
| pI | Theoretical isoelectric point |
| PSGL-1 | P-selectin glycoprotein ligand-1 |
| PtdSer | Phosphatidylserine |
| PVR | Poliovirus receptor |
| PVRIG | Poliovirus receptor-related immunoglobulin domain-containing protein |
| ROS | Reactive oxygen species |
| SELPLG | Selectin P ligand gene |
| TAM | Tumor-associated macrophage |
| TCR | T-cell receptor |
| Tfh | T follicular helper cell |
| TIGIT | T-cell immunoreceptor with Ig and ITIM domains |
| TILs | Tumor-infiltrating lymphocytes |
| TIM-3 | T-cell immunoglobulin and mucin-domain containing-3 |
| TLS | Tertiary lymphoid structures |
| TMB | Tumor mutational burden |
| TME | Tumor microenvironment |
| TNF | Tumor necrosis factor |
| TNFRSF | Tumor necrosis factor receptor superfamily |
| TNFSF | Tumor necrosis factor superfamily |
| TRAF1 | TNF receptor-associated factor 1 |
| TRAF2 | TNF receptor-associated factor 2 |
| TRAF3 | TNF receptor-associated factor 3 |
| Treg | Regulatory T cell |
| VISTA | V-domain Ig suppressor of T-cell activation |
| VSIR | V-set immunoregulatory receptor |